Posts by admin

The first round of voting for STAT Madness began today. Included in the first round is the BIDMC team, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), who in collaboration with Johnson & Johnson developed and conducted preclinical testing of a single-dose COVID-19 vaccine, which is one of three COVID-19 vaccines cleared for emergency use in the U.S.

STAT Madness has begun. Vote for the best innovations in biomedicine

+ Read More

FDA issues emergency use authorization for Johnson & Johnson vaccine

Medical experts on Friday unanimously recommended that...

+ Read More

The Johnson & Johnson vaccine, which was developed in collaboration with BIDMC, was authorized Saturday for use in the U.S. Experts in gene-based technology, including Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), produced a class of vaccines they believe can protect against all manner of outbreaks in the years to come.

Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease

+ Read More

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) led the team that developed the vaccine in a collaboration between Johnson & Johnson and BIDMC, and shared what its approval will mean for the state of Massachusetts’s vaccination efforts.

Johnson & Johnson Vaccine ‘Particularly Good For Mass Vaccination Campaigns,’ Boston Doctor Says

+ Read More

According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

What the latest Johnson & Johnson COVID vaccine data really means

+ Read More

Kevin Tabb, MD (CEO, BILH) joined leadership from local hospitals on the ‘Future of Health Care’ panel and noted health care is moving beyond the four walls of a hospital to any place it’s needed including physician’s offices, community health centers, or a patient’s home.

'Future of Health Care' panel: Pandemic drives system integration, anti-racism efforts

+ Read More

According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

New analyses show Johnson & Johnson’s one-dose vaccine works well.

+ Read More

A research team at BIDMC led by James E. Kirby, MD (Clinical Microbiology, BIDMC) and Ramy Arnaout, MD (Clinical Microbiology, BIDMC) has developed a mathematical model to estimate the false negative rate for COVID-19 tests.

Beth Israel Deaconess researchers build tool to estimate false negative COVID-19 test rates

+ Read More

BIDMC researchers build tool to estimate false negative COVID-19 test rates

A research team at BIDMC led by James E. Kirby...

+ Read More

Advisers are set the meet this week to discuss the recommendation of the Johnson & Johnson one-shot vaccine for emergency use authorization. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) noted the process needs to be accelerated for vaccine rollout in the United States and throughout the world.

Local doctor who assisted in development of J&J vaccine says having another option is critical

+ Read More

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) noted that the urgency of the COVID-19 pandemic, combined with advances in funding and technology, enabled the vaccine to be a global effort.

How to have a conversation with someone who’s hesitant about the Covid vaccine

+ Read More

Kevin P. Hill, MD (Addiction Psychiatry, BIDMC) shared how people with substance use disorder have been hit especially hard by the COVID-19 pandemic and what the Division of Addiction Psychiatry at BIDMC is doing to address this problem.

The stress and worry that came with the pandemic have proved to be a stern test of the coping strategies for those with substance use disorder.

+ Read More

Sharon Wright, MD, MPH (Infectious Disease, BIDMC) speaks about the latest COVID-19 headlines, including the pace of the vaccine rollout, what the FDA Advisory Committee takes into consideration as they consider a vaccine candidate for emergency use authorization, whether COVID-19 could be a season virus, as well as the sobering milestone of 500,000 lives lost during this pandemic.

Mass. doctor on COVID-19 case, hospitalization drop

+ Read More

As the pandemic stretches toward the one-year mark, with about half a million deaths in the U.S. alone, some healthcare workers are staying creative to cope with stress or to share a message of hope with their community. During the pandemic, Michael Gibson, MD (Interventional Cardiology, BIDMC) created about ten paintings, including one painting that was auctioned off to support healthcare workers.

Healthcare workers are turning to art to cope. Here are some of their projects

+ Read More

As Massachusetts and several other states prioritize vaccine distribution to residents with cancer, heart disease, obesity and other medical concerns, many are still trying to figure out if they qualify as criteria with these diseases remain unclear. Sean Levy, MD (Pulmonary Disease, BIDMC) noted some eligible risk factors like smoking are open to interpretation.

Do I Qualify? Vaccine Confusion For Patients With Multiple Serious Medical Conditions

+ Read More

The Gazette recently contacted experts to ask about a few surprising, unanticipated positives that have emerged midst pandemic. In the area of health care delivery, almost 90 percent of the visits at BIDMC’s primary care practice had to switch to telephone or video interviews which makes for fully open and transparent communication even more important.

Various innovations, rise of women leaders, greater collaboration between scientists, clinicians, to name few

+ Read More

The state has been criticized for its inoculation work, absorbing complaints about logistical hurdles and cumbersome technology. Edward Ullman, MD (Emergency Medicine, BIDMC) noted the only way to address those complaints is to take the criticism, listen to it and figure out how to make it better.

The latest Fenway faithful want it now. They want it fast

+ Read More

In the fight toward herd COVID-19 immunity, Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to the importance of vaccine-induced T cell responses, particularly for resistant variants that might partially evade neutralizing antibodies.

How soon will COVID-19 vaccines return life to normal?

+ Read More

Roger Shapiro, MD (Infectious Disease, BIDMC) is among four Boston-area doctors who spoke with GBH News about what to expect when getting either the Moderna or Pfizer vaccines.

What To Expect After Getting A COVID-19 Vaccine

+ Read More

Epidemiologists said the U.K. coronavirus variant may be the dominant strain of the virus in the United States by March. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) noted even more worrisome is the variant from South Africa as it’s not only more contagious but it’s also partially resistant to antibodies.

The microbiology lab at Massachusetts General Hospital is joining ramped-up efforts underway through the state and the Broad Institute to identify variants in Massachusetts communities.

+ Read More